ACARIX — Acarix AB Share Price
Last Trade - 00:00- SEK201.41m
- SEK147.47m
- SEK2.77m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | 0.64 | 1.02 | 1.86 | 2.17 | 7 | 16 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Directors
- Werner Braun
- Christian Lindholm (54)
- Claus Christensen
- Anja Schaefer
- Claus Andersson (52)
- Yun Fei Hong
- Ulf Rosen (60)
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- January 1st, 1970
- Public Since
- December 19th, 2016
- No. of Employees
- 9
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 141,045,437
- Address
- Jungmansgatan 12, MALMO, 211 19
- Web
- https://acarix.com/
- Phone
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Latest News for ACARIX
Upcoming events for ACARIX
Q3 2021 Acarix AB Earnings Release
Similar to ACARIX
BIOTAGE ORD
OMX Nordic Exchange Stockholm
CELLAVISION ORD
OMX Nordic Exchange Stockholm
IMMUNOVIA ORD
OMX Nordic Exchange Stockholm
PHARMACOLOG I UPPSALA ORD
OMX Nordic Exchange Stockholm
SCANDIDOS ORD
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:54 UTC, shares in Acarix AB are trading at SEK1.43. This share price information is delayed by 15 minutes.
Shares in Acarix AB last closed at SEK1.43 and the price had moved by +73.72% over the past 365 days. In terms of relative price strength the Acarix AB share price has outperformed the FTSE Global All Cap Index by +34.89% over the past year.
There is no consensus recommendation for this security.
Acarix AB does not currently pay a dividend.
Acarix AB does not currently pay a dividend.
Acarix AB does not currently pay a dividend.
To buy shares in Acarix AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK1.43, shares in Acarix AB had a market capitalisation of SEK201.41m.
Here are the trading details for Acarix AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: ACARIX
Based on an overall assessment of its quality, value and momentum Acarix AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Acarix AB is SEK1.32. That is 7.56% below the last closing price of SEK1.43.
Analysts covering Acarix AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK1.01 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Acarix AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -2.86%.
As of the last closing price of SEK1.43, shares in Acarix AB were trading +3.62% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Acarix AB.
Acarix AB's management team is headed by:
- Werner Braun -
- Christian Lindholm -
- Claus Christensen -
- Anja Schaefer -
- Claus Andersson -
- Yun Fei Hong -
- Ulf Rosen -
We do not have data on Acarix AB's shareholders